Silicon Valley Bank and Oxford Finance to further strengthen our cash position.” EQUALISE is a Phase 1b multiple ascending dose trial that is evaluating the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD), and clinical activity of itolizumab in...
The Pitt Hopkins Research Foundation announces its first-ever human clinical trial to attempt to eradicate the severe gastrointestinal effects of Pitt-Hopkins syndrome (PTHS), a rare disorder caused by a mutation of the TCF4 gene (18 chromosome) and often classified...
Equillium, Inc. (NASDAQ: EQ) today announced it has initiated the EQUALISE Phase 1b clinical trial of itolizumab (EQ001) in patients with lupus nephritis and provided an update on its ongoing clinical programs. Additionally, Equillium announced an agreement with...
Preclinical and Phase 1 data support the evaluation of SRK-015 in ongoing Phase 2 trial for the treatment of patients with Type 2 and Type 3 spinal muscular trophy CAMBRIDGE, Mass., Oct. 02, 2019 (GLOBE NEWSWIRE) — Scholar Rock (SRRK), a clinical-stage...
“If you have a patient who complains that their sleep has taken a turn for the worse then there is reason to open the door to a question about suicide,” says Vaughn McCall, MD, chair of the Department of Psychiatry and Health Behavior at the Medical College of Georgia...
Email
Text